Does alternation of Candida albicans TUP1 gene expression affect the progress of symptomatic recurrent vulvovaginal candidiasis?
- PMID: 33628975
- PMCID: PMC7888521
- DOI: 10.18502/CMM.6.2.2694
Does alternation of Candida albicans TUP1 gene expression affect the progress of symptomatic recurrent vulvovaginal candidiasis?
Abstract
Background and purpose: Recurrent vulvovaginal candidiasis (RVVC) is one of the most common gynecological conditions in healthy and diabetic women, as well as antibiotic users. The present study was conducted to determine the relationship between TUP1 gene expression patterns and symptomatic recurrent C. albicans infections.
Materials and methods: This research was performed on C. albicans samples isolated from the vaginal specimens obtained from 31 individuals with RVVC in 2016. The reference strain C. albicans ATCC 10231, 10 C. albicans strains isolated from minimally symptomatic patients, and 10 isolates from asymptomatic patients were also used as control strains. The relative mRNA expression of the TUP1 gene was quantified using quantitative real-time polymerase chain reaction (QRT-PCR).
Results: The QRT-PCR results revealed that TUP1 mRNA expression was significantly decreased (0.001-0.930 fold) in the C. albicans isolates obtained from RVVC patients (P<0.001). However, no TUP1 expression was detectable in the isolates collected from asymptomatic patients. The results also indicated a significant correlation between TUP1 mRNA expression level and the severity of itching and discharge (P<0.001).
Conclusion: The present results were suggestive of the probable contribution of TUP1, as a part of the transcriptional repressor, to the severity of the symptoms related to C. albicans infections in the vagina. Regarding this, it is required to perform more in vivo studies using a larger sample size to characterize the regulatory or stimulatory function of TUP1 in the severity of RVVC symptoms. Furthermore, the study and identification of the genes involved in the severity of the symptomatic manifestations of C. albicans, especially in resistant strains, may lead to the recognition of an alternative antifungal target to enable the development of an effective agent.
Keywords: Expression; Filamentous growth; Vulvovaginal candidiasis; Candida albicans; TUP1 gene.
Copyright: © 2020, Published by Mazandaran University of Medical Sciences on behalf of Iranian Society of Medical Mycology and Invasive Fungi Research Center.
Figures
Similar articles
-
Difference Between the Profiles Presented by Yeasts that Colonize the Vaginal Mucosa or Cause Primary or Recurrent Candidiasis.Mycopathologia. 2021 Jun;186(3):411-421. doi: 10.1007/s11046-021-00556-y. Epub 2021 Jun 13. Mycopathologia. 2021. PMID: 34120275
-
Differential expression of Candida albicans secreted aspartyl proteinase in human vulvovaginal candidiasis.Mycoses. 2007 Sep;50(5):383-90. doi: 10.1111/j.1439-0507.2007.01384.x. Mycoses. 2007. PMID: 17714358
-
Microsatellite analysis of Candida isolates from recurrent vulvovaginal candidiasis.J Med Microbiol. 2012 Aug;61(Pt 8):1091-1096. doi: 10.1099/jmm.0.043992-0. Epub 2012 Apr 26. J Med Microbiol. 2012. PMID: 22538998
-
Immunopathogenesis of recurrent vulvovaginal candidiasis.Clin Microbiol Rev. 1996 Jul;9(3):335-48. doi: 10.1128/CMR.9.3.335. Clin Microbiol Rev. 1996. PMID: 8809464 Free PMC article. Review.
-
Recurrent vulvovaginal candidiasis.Am J Obstet Gynecol. 2016 Jan;214(1):15-21. doi: 10.1016/j.ajog.2015.06.067. Epub 2015 Jul 9. Am J Obstet Gynecol. 2016. PMID: 26164695 Review.
References
-
- Lema VM. Recurrent vulvo-vaginal candidiasis: diagnostic and management challenges in a developing country context. Obstet Gynecol Int J. 2017; 7(5):260.
-
- Ghazanfari M, Falahati M, Fattahi A, Bazrafshan F, Nami S, Hosseinzadeh M, et al. Is MBL serum concentration a reliable predictor for recurrent vulvovaginal candidiasis? . Mycoses. 2017; 62(2):106–11. - PubMed
LinkOut - more resources
Full Text Sources